Insider Trading Screener
| Ticker | Issuer Name | Owner Name | Relationship | Transaction Date | Transaction | Shares | Price/Share | Total Value | Shares Owned |
|---|---|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Director | 2026-01-12 | C - A | 202,862 | 0.00 | 0.00 | 202,862 |
| AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Director | 2026-01-12 | C - A | 128,506 | 0.00 | 0.00 | 128,506 |
| AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Director | 2026-01-12 | P - A | 2,077,779 | 18.00 | 37,400,022.00 | 4,348,658 |
| AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Director | 2026-01-12 | P - A | 144,443 | 18.00 | 2,599,974.00 | 347,305 |
| AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Director | 2026-01-12 | C - D | 9,913,810 | 0.00 | 0.00 | 0 |
| AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Director | 2026-01-12 | C - D | 997,299 | 0.00 | 0.00 | 0 |
| AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Director | 2026-01-12 | C - D | 488,891 | 0.00 | 0.00 | 0 |
| AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Director | 2026-01-12 | C - D | 2,397,500 | 0.00 | 0.00 | 0 |
| AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Director | 2026-01-12 | C - D | 102,500 | 0.00 | 0.00 | 0 |
| AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Director | 2026-01-12 | C - A | 965,190 | 0.00 | 0.00 | 965,190 |
| AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Director | 2026-01-12 | C - A | 86,222 | 0.00 | 0.00 | 86,222 |
| AKTS | Aktis Oncology, Inc. | Kim Helen Susan | 2026-01-12 | C - A | 4,859,370 | 0.00 | 0.00 | 4,859,370 | |
| AKTS | Aktis Oncology, Inc. | Kim Helen Susan | 2026-01-12 | P - A | 812,455 | 18.00 | 14,624,190.00 | 5,671,825 | |
| AKTS | Aktis Oncology, Inc. | Kim Helen Susan | 2026-01-12 | C - A | 134,842 | 0.00 | 0.00 | 134,842 | |
| AKTS | Aktis Oncology, Inc. | Kim Helen Susan | 2026-01-12 | P - A | 22,545 | 18.00 | 405,810.00 | 157,387 | |
| AKTS | Aktis Oncology, Inc. | Kim Helen Susan | 2026-01-12 | C - D | 14,838,250 | 0.00 | 0.00 | 0 | |
| AKTS | Aktis Oncology, Inc. | Kim Helen Susan | 2026-01-12 | C - D | 411,750 | 0.00 | 0.00 | 0 | |
| AKTS | Aktis Oncology, Inc. | Kim Helen Susan | 2026-01-12 | C - D | 3,648,750 | 0.00 | 0.00 | 0 | |
| AKTS | Aktis Oncology, Inc. | Kim Helen Susan | 2026-01-12 | C - D | 101,250 | 0.00 | 0.00 | 0 | |
| AKTS | Aktis Oncology, Inc. | Segal Lloyd Mitchell | 2026-01-12 | C - A | 19,631 | 0.00 | 0.00 | 19,631 | |
| AKTS | Aktis Oncology, Inc. | Segal Lloyd Mitchell | 2026-01-12 | C - D | 50,000 | 0.00 | 0.00 | 0 | |
| AKTS | Aktis Oncology, Inc. | Segal Lloyd Mitchell | 2026-01-12 | C - D | 24,687 | 0.00 | 0.00 | 0 | |
| AKTS | Aktis Oncology, Inc. | VIDA VENTURES II-A, LLC | 2026-01-12 | C - A | 4,859,370 | 0.00 | 0.00 | 4,859,370 | |
| AKTS | Aktis Oncology, Inc. | VIDA VENTURES II-A, LLC | 2026-01-12 | P - A | 812,455 | 18.00 | 14,624,190.00 | 5,671,825 | |
| AKTS | Aktis Oncology, Inc. | VIDA VENTURES II-A, LLC | 2026-01-12 | C - A | 134,842 | 0.00 | 0.00 | 134,842 |